CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Seres Therapeutics

For profitContributed to NMEWebsite ↗

Also known as: Seres Therapeutics, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

May 1, 2015

First marketed drug

Apr 26, 2023

First NDA

Apr 26, 2023

Last known activity

Apr 26, 2023

Timeline

2010s

  1. Jun 1, 2010

    Seres Therapeutics— Founded

2020s

  1. Apr 26, 2023

    fecal microbiota spores, live-brpk— NDA Organization

  2. Apr 26, 2023

    fecal microbiota spores, live-brpk— NDA Secondary Org

Drugs by trial phase (7 distinct, 9 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (16)

Details

Founded
Cambridge, MA, US Jun 1, 2010
First NDA
Apr 26, 2023
Last known activity
Apr 26, 2023

Designations held

  • Orphan drug
  • Breakthrough therapy